Programmatic considerations for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis

Megan Auzenbergs, Clara Maure, Hyolim Kang, Oliver Brady, Sushant Sahastrabuddhe, Kaja Abbas
doi: https://doi.org/10.1101/2023.09.26.23296129

Article Information

doi 
https://doi.org/10.1101/2023.09.26.23296129
History 
  • September 26, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Megan Auzenbergs1,#,
  2. Clara Maure2,
  3. Hyolim Kang1,
  4. Oliver Brady1,
  5. Sushant Sahastrabuddhe2,* and
  6. Kaja Abbas1,3,*
  1. 1London School of Hygiene and Tropical Medicine, London, UK
  2. 2International Vaccine Institute, Seoul, South Korea
  3. 3School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
  1. ↵#Correspondence: megan.auzenbergs{at}lshtm.ac.uk

  1. ↵* Contributed equally

Back to top
Posted September 26, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Programmatic considerations for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: stakeholder analysis
Megan Auzenbergs, Clara Maure, Hyolim Kang, Oliver Brady, Sushant Sahastrabuddhe, Kaja Abbas
medRxiv 2023.09.26.23296129; doi: https://doi.org/10.1101/2023.09.26.23296129
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area